Back to Search Start Over

Cerebral hemodynamics in the non-alcoholic fatty liver.

Authors :
Vidal-González D
López-Sánchez GN
Concha-Rebollar LA
Rodríguez-Herrera A
Morales-Ramirez F
Chávez-Tapia N
Uribe M
Nader-Kawachi JA
Nuño-Lámbarri N
Source :
Annals of hepatology [Ann Hepatol] 2020 Nov - Dec; Vol. 19 (6), pp. 668-673. Date of Electronic Publication: 2020 Jul 16.
Publication Year :
2020

Abstract

Introduction and Objectives: The association between non-alcoholic fatty liver disease and cerebral hemodynamics arises from cardiovascular damage mechanisms such as endothelial dysfunction, arterial wall increased stiffness, high thickness of the intimate index of the internal carotid artery, left ventricular hypertrophy, left diastolic dysfunction, calcification coronary arteries and increased epicardial fat. The multidirectional relationship between systemic inflammation and lipid metabolism constitutes a common and simultaneous mechanism that causes vascular damage. This study aims to provide insight into the relationship between non-alcoholic fatty liver disease and the function of systemic circulation and cerebral circulation using Doppler ultrasound.<br />Patients and Methods: Is an observational, cross-sectional, prospective, comparative study conducted at Medica Sur Hospital. Thirty-five patients were selected consecutively. The patients consulted neurological service for various symptoms without severity criteria, such as vertigo, primary headache and balance disturbances.<br />Results: There is a difference in the variables mean of the right MCA PI (p = 0.023), left MCA PI" (p = 0.004), and left VA PI (p = 0.036) between the control and NAFLD groups. The correlation analysis between these variables and the CAP showed a positive correlation of the three variables with the CAP, "right MCA PI" (r = 0.384), left MCA PI "(r = 0.509) and" left VA PI " (r = 0.551).<br />Conclusions: This study demonstrates a subclinical process of the middle cerebral artery in subjects with NAFLD, which suggests it may be involved in the disease development and points the need to make decisions for this liver manifestation prevention and treatment.<br /> (Copyright © 2020 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.)

Details

Language :
English
ISSN :
1665-2681
Volume :
19
Issue :
6
Database :
MEDLINE
Journal :
Annals of hepatology
Publication Type :
Academic Journal
Accession number :
32683094
Full Text :
https://doi.org/10.1016/j.aohep.2020.06.006